Motivation: We introduce TRONCO (TRanslational ONCOlogy), an open-source R package that implements the state-of-the-art algorithms for the inference of cancer progression models from (epi)genomic mutational profiles. TRONCO can be used to extract population-level models describing the trends of accumulation of alterations in a cohort of cross-sectional samples, e.g., retrieved from publicly available databases, and individual-level models that reveal the clonal evolutionary history in single cancer patients, when multiple samples, e.g., multiple biopsies or single-cell sequencing data, are available. The resulting models can provide key hints in uncovering the evolutionary trajectories of cancer, especially for precision medicine or personalized therapy.
Introduction
Cancer develops through the successive expansions of clones, in which certain (epi)genomic alterations, called drivers, confer a fitness advantage and progressively accumulate, in a context of overall scarcity of resources [6] . Specifically, in Nowell's seminal work, tumor evolution is described in terms of stepwise genetic variation such that growth advantage is the key for the survival and prorogation of the clones. Therefore, one can define cancer progression models, in terms of probabilistic Figure 1 : (A) TRONCO can process either alterations (e.g., somatic mutations or wider chromosomal lesions) in a cohort of independent samples (top lolliplot diagram), or a set of multiple snapshots from a unique patient (e.g., multi-region or single-cell, bottom panel). (B) Oncoprints allow the user to visualize the data that the tool is processing. Regardless of the source, each row represents a certain alteration -at a custom resolution depending on the cancer under study -and each column a sample. (C) A model inferred with the tool might outline cancer evolution occurring in a population ensemble or in an individual patient. Graphically, alterations are represented as nodes with different colors (e.g., green mutations and blue homozygous deletions). Algorithms such as CAPRI allow describing alterations with logical formulas, in an attempt to find their role as a "group" (see [8] for details); we picture such groups with dashed lines. In the panel, we show a hypothetical ensemble-level model predicting a selection pressure on two genes mapped to 17p13, tp53 and hic1, as it may be inferred by analyzing samples harbouring either tp53/hic1 mutations or homozygous deletions in the cytoband where any of these two genes map, i.e., here for purely explanatory cases we suppose just tp53, which maps to 17p13.1. The model suggests a trend of selection towards mutations in gene y, which shall be interpreted as a set of preferential clonal expansions characteristic of the population of analyzed samples, involving alterations of the functions mapped to 17p13 and y. (D) TRONCO supports three data types. Custom data, which is supposed to be provided as a binary input matrix storing the presence (1) or absence (0) of a certain alteration in a sample. Or, standard data formats such as the Mutation Annotation Format (MAF) for somatic mutations, as well as the Genomic Identification of Significant Targets in Cancer (GISTIC) format for focal Copy Number Variations. Data can be generated by custom experiments, or collected -along with other "omics" -from public databases such as TCGA and cBio portal. For the latter, cBio portal, TRONCO implements a query system to fetch data with minimal effort. The tool engine can then be used to manipulate genomic profiles -regardless of their source -and run progression inference algorithms.
causal graphical models, where the conditional dependencies and the temporal ordering among these alterations are described, revealing the evolutionary trajectories of cancer at the (epi)genome level.
We further distinguish [3] . (i) ensemble-level progression models, describing the statistical trends of accumulation of genomic alterations in a cohort of distinct cancer patients. Such models describe the temporal partial orders of fixation and accumulation of such alterations and represent population-level trends; and (ii) individual-level models, thus accounting for the specific evolutionary history of cancer clones in individual tumors. Such models thus impute the ancestry relations of the observed clones.
Even if the inference of such models is further complicated by a series of theoretical and technical hurdles, such as, e.g., intra-and inter-tumor heterogeneity and the effective detection of drivers, it can benefit from the increasing amount of next-generation sequencing (NGS) data, currently available through public projects such as The Cancer Genome Atlas (TCGA, https://tcga-data. nci.nih.gov). Usually, such databases provide cross-sectional (epi)genomic profiles retrieved from single biopsies of cancer patients, which can be used to extract ensemble-level models; but higher resolution data such as multiple-biopsies, or even single-cell sequencing data are becoming more accessible and reliable, which can be used to infer individual-level models.
Here we introduce TRONCO (TRanslational ONCOlogy), an R package built to infer cancer progression models from heterogeneous genomic data (in the form of alterations persistently present along tumor evolution.) Currently, TRONCO provides the implementation of two algorithms: (i) CAPRESE (CAncer PRogression Extraction with Single Edges [7] ), and (ii) CAPRI (CAncer PRogression Inference [8] ), both based on Suppes' theory of probabilistic causation [9] , but with distinct goals and properties (see Software Implementation).
TRONCO, in its current form and perspective, should be thought of as a tool that provides the implementation of up-to-date solutions to the progression inference problem. At the time of the writing it can be effectively used as the final stage of a modular pipeline for the extraction of ensemble-level cancer progression models from cross-sectional data [3] . In such a pipeline input data are pre-processed to (i) stratify samples in tumor subtypes, (ii) select driver alterations and (iii) identify groups of fitness-equivalent (i.e., mutually exclusive) alterations, prior to the application of the CAPRI algorithm. The resulting ensemble-level progression models depict the evolutionary dynamics of cancer, with translational impacts on diagnostic and therapeutic processes, especially in regard to precision medicine and personalized drug development.
From the complementary perspective, TRONCO can also exploit the CAPRESE algorithm to infer the clonal evolutionary history in single patients when multiple samples are available, as in the case of multiple biopsies and/or single-cell sequencing data, as long as the set of driver events is selected; see [3] .
Software Implementation
TRONCO implements a set of R functions to aid the user to extract a cancer progression model from genomic data. At a high-level, these function shall help to import, visualize and manipulate genomic profiles -regardless of their source -eventually allowing the implemented algorithms to run and assess the confidence in a model.
The basics steps of TRONCO's usage are shown in Figure 1 . In panel (a) we show multiple input alterations (e.g., somatic mutations or copy number alterations) either from a cohort of patients, or a unique patient (e.g., multi-region or single-cell sequencing); in panel (b) we show an oncoprint visualization from the tool, i.e., a matrix whose columns represent samples and rows the alterations and their presence per sample; panel (c) shows an inferred graphical Bayesian progression model obtained with one of the available algorithms; finally, in panel (d) we show data supported for processing in the tool. For a more detailed explanation of the implementation of the package see [1] .
Data loading and manipulation. Common formats to store data used to extract progression models can be natively imported. These include, for instance, the Mutation Annotation Format (MAF) for somatic mutations, as well as the Genomic Identification of Significant Targets in Cancer (GISTIC) format to store focal Copy Number Variations. The tool can exploit the cBio portal for Cancer Genomics, which collects among others TCGA projects, to access freely available instances of such data [4] .
TRONCO provides functions for data preprocessing to, e.g., select a certain subset of alterations, or samples or any abstraction which might be appropriate according to the cancer being studied.
Visualization and interaction with other tools. TRONCO implements an oncoprint system to visualize the processed data. Datasets can be exported for processing by other tools used to, e.g., stratify input samples and detect groups of mutually exclusive alterations, which include the Network Based Stratification [5] and MUTEX [2] tools. TRONCO allows the visualization of the inferred models.
Model inference and confidence. TRONCO provides two algorithms: (i) CAPRESE, which uses a shrinkage-like estimator to infer tree-models of progression, and (ii) CAPRI, which extracts more general direct acyclic graphs (DAG) -thus allowing for confluent evolution and complex hypothesis testing -by combining bootstrap and maximum likelihood estimation. CAPRESE and CAPRI both rely on the same theory of probabilistic causation, but with distinct goals and properties. The former reconstructs tree models of progressions, while the latter general directed acyclic graphs. Both methods are agnostic to the type of input data (i.e., whether its an ensemble or an individual tumor), but shall be used in different contexts as they produce different types of models. Indeed, CAPRESE is better at extracting cancer evolution in a single individual as in that case trees capture branched evolution and trunk events, which shall suffice to describe clonal evolution. Instead, when heterogeneity might result in multiple evolutionary routes with common downstream alterations, the underlying true model is a graph, and CAPRI should be the tool of choice.
Whatever a model is, TRONCO implements a set of functions to assess its confidence via (i) non-parametric, (ii) parametric and (iii) statistical bootstrap.
Discussion
TRONCO provides up-to-date, theoretically well-founded, statistical methods to understand the evolution of a cancer (ensamble-level) or a single tumor (individual-level). The implemented algorithms are demonstrably the state-of-the-art for the progression inference problem, in terms of computational cost, scalability with respect to sample size, accuracy and robustness against noise in the data. The implementation makes straightforward the interaction of TRONCO with other common bioinformatics tools, possibly allowing the creation of a common suite of tools for cancer progression inference.
Finally, we refer to [3] or the Supplementaty materials for a demonstration of the usage of TRONCO on real genomics data both at the ensemble-level and individual-level progression models. In particular, this paper outlines the capability of the methods to reproduce much of the current knowledge on the progression for a set of cancer types, as well as to suggest clinically relevant insights. Furthermore, we also provide users with detailed manuals, vignettes, and source code to replicate all the analysis presented in the paper plus others (case studies: colorectal cancer, clear cell renal cell carcinoma and acute chronic myeloid leukaemia) in the Supplementary Materials and at the TRONCO official webpage (Software section at http://bimib.disco.unimib.it/). TRONCO: an R package for the inference of cancer progression models from heterogeneous genomic data This can be installed from our GitHub account by typing within R the following commands:
Mantis Shrimp is also in Bioconductor 3.2 since 14 October 2015.
Examples
TRONCO official webpage (http://bimib.disco.unimib.it/) hosts detail commentary and source code to replicate the following studies:
1. Atypical Chronic Myeloid Leukemia (aCML) -ensemble level; In the next subsections we present a few examples of usage of the tool.
Fetching data from the cBio portal
We show how to download lung cancer data of somatic mutations reported in Figure 1 The code that we show is tested under R's most recent version.
Fetching data. First, define the pool of genes for which one wishes to download data. In this case we have a list of 18 genes from the reference figure.
Data in cBio portal are identified by the following triple:
• a study ID -a high-level references of the study, here luad tcga pub;
• a dataset ID -a set of samples which are part of the study, in our case luad tcga pub cnaseq;
• a genetic profile ID -a type of data available for those samples, here luad tcga pub mutations.
With these references, one can extract data from the portal. If these are not known in advance, one can run TRONCO's function cbio.query which wraps the CGDS-R package -the official query system for the portal, in R.
This function will help you by showing the available data at the portal: Here from a list of IDs archived at the portal, and we have selected the one which references the data used in the manuscript. Notice that the user can also access provisional TCGA data or datasets from other studies such as those carried out at the Broad Institute of MIT and Harvard.
The function cbio.query will then load dataset information and will allow the user to select the set of desired samples, in this case we select all tumor samples that have CNA and sequencing data. In this way we collected 230 samples and 5 genes, plus the function automatically downloads clinical data for the selected samples. All these data are exported to an Rdata file named for this query luad tcga pub.luad tcga pub cnaseq.luad tcga pub mutations.Rdata so that further processing can happen offline.
From data to a TRONCO object. The returned object, here data, has flags to access the retrieved data. Mutation data is available through $profile tag, clinical data through $clinical tag. Basic conversion to this format to a representation which can be imported with TRONCO is straightforward, as we can go through a conversion to R's matrix, replace string values with corresponding 0s and 1s -as in this case we are not distinguishing types of mutations -, and transform the matrix in a tronco object via import.genotypes.
The imported dataset can be seen in the console with show, and visualized via oncoprint. The image obtained is shown in figure 1 . The reconstruction of a progression model is straightforward. For instance, to use CAPRI algorithm -with its default settings -and set a few graphical parameters to scale nodes size as of events' frequencies, scale legend which gets displayed in top corners and show p-values for the two elements which constitute the statistical evidence of selective advantage (temporal priority and probability raising) and hypergeometric test. In a similar way, one might download, e.g., GISTIC data for CNAs, merge it to these mutations -via TRONCO's functions -and build a model with both data types included.
Clonal architecture of Clear Cell Renal Cell Carcinoma (CCRCC)
We now adopt the public data from Gerlinger et al., Nat Gen 46, 2014 to show that the presented algorithms can be used to successfully reconstruct the clonal architecture in individual patients. We consider data coming from multi-region targeted exome-sequencing with high coverage (> 70x), which are reported in the reference paper as figures and in the supplementary materials.
Text files of the genetic profiles provided in such supplementary resources have been given as input to TRONCO and imported with the following R function (i.e., import.sample).
# Import data -this converts the data from the CSV text file # obtained from Excel, to a TRONCO object import.sample = function(filename) { data = as.matrix(read.csv(paste0(filename), header=F)) curr.data = NULL curr.data$genotypes = apply(data[c(-1,-2), -1, drop=F], 2, as.numeric) rownames(curr.data$genotypes) = data[c(-1,-2),1] curr.data$annotations = matrix(c(data [2, -1] , data [1, -1] ), ncol=2) event.names = c() for(i in 1:nrow(curr.data$annotations)){ event.names = c(event.names, paste0("G",i)) } colnames(curr.data$genotypes) = event.names rownames(curr.data$annotations) = event.names colnames(curr.data$annotations) = c("type", "event") curr.data$types = matrix ('', nrow=length(unique(data[2, -1] )), ncol=1) colnames(curr.data$types) = "color" rownames(curr.data$types) = unique(data [2, -1] As an example, we next show the R code used to import the data for one of the patients (RM H004) from the study. > library("TRONCO") > library(RColorBrewer) > colors = c(brewer.pal(6, "Set2"), "firebrick4", "dodgerblue4") > types = c("Merged", "Frame Shift", "Splice site", "SNV", > "Stop codon", "Disrupts start codon", "Gain", > "Loss") > rmh004.mut = import.sample("RMH004.csv") $genotypes G1 G2 G3 G4 G5 G6 R3 
Now we load the CNAs and trim any event with no observations > rmh004.CNA = import.sample("RMH004G.csv") $genotypes G1 G2 G3 G4 G5 G6 G7 G8 G9 G10 G11 "1q25.1" G2 "Gain" "2q14.3" G3 "Gain" "5q35.3" G4 "Gain" "7q22.3" G5 "Gain" "8q24.21" G6 "Gain" "12p11.21" G7 "Gain" "20q13.33" G8 "Loss" "1p36.11" G9 "Loss" "3p25.3" G10 "Merged" "4q34.3-/8p23.2-/9p21.3-/14q31.1-" G11 "Loss" "6q22.33"
We use the intersect function of TRONCO to merge mutations profile with CNAs > rmh004.data = intersect.datasets(rmh004.CNA, rmh004.mut, > intersect.genomes = F) *** Binding events for 2 datasets. *** Intersect dataset [ intersect.genomes = FALSE ]
x y result Samples 7 7 7 Genes 9 6 15
The obtained TRONCO object has then been further edited in order to detect and handle genes with the same mutational profiles. We have to process these data as some alterations have the same genomic profile e.g., 5q35.3 amp, VHL fs and 3p25.3 loss. We get a report of these events with the function consolidate.data. > duplicated.events = consolidate.data(rmh004.data, T) Indistinguishable events: type event G1 "Gain" "1q25.1" G4 "Gain" "7q22.3" G6 "Gain" "20q13.33" G8 "Merged" "4q34.3-/8p23.2-/9p21.3-/14q31.1-" G12 "Merged" "PBRM1(FS)/ATM(SC)" Total number of events for these genes: 5 Indistinguishable events: type event G2 "Gain" "2q14.3" G5 "Gain" "12p11.21" Total number of events for these genes: 2 Indistinguishable events: type event G3 "Gain" "5q35.3" G7 "Loss" "3p25.3" G10 "Frame Shift" "VHL" Total number of events for these genes: 3
We use merge.events to merge the indistinguishable events > rmh004.data = merge.events(rmh004.data, > "G1", "G4", "G6", "G8", "G12", > new.event = '1q 7q 20q 4q .. PBRM1fs ATMsc', > new.type = 'Merged', > event.color = as.colors(rmh004.data)['Merged']) *** Binding events for 2 datasets.
Then we re-check the IDs of the events as data were edited in the previous step > duplicated.events = consolidate.data(rmh004.data, T) Indistinguishable events: type event G1 "Gain" "2q14.3" G3 "Gain" "12p11.21" Total number of events for these genes: 2 Indistinguishable events: type event G2 "Gain" "5q35.3" G4 "Loss" "3p25.3" G6 "Frame Shift" "VHL" Total number of events for these genes: 3 > rmh004.data = merge.events(rmh004.data, > "G1", "G3", > new.event = '2q 12p', > new.type = 'Merged', > event.color = as.colors(rmh004.data)['Merged']) *** Binding events for 2 datasets.
> duplicated.events = consolidate.data(rmh004.data, T) Indistinguishable events: type event G1 "Gain" "5q35.3" G2 "Loss" "3p25.3" G4 "Frame Shift" "VHL" Total number of events for these genes: 3 > rmh004.data = merge.events(rmh004.data, > "G1", "G2", "G4", In Figure 2 we show the clonal evolution estimated for one of those patients, RM H004, computed with CAPRESE (shrinkage coefficient λ = 0.5, time < 1 sec) from the Bernoulli 0/1 profiles provided in Supplementary Table 3 and Figure 4 of the reference paper, with non-parametric bootstrap confidence (time < 1 sec).
> rmh004.data = tronco.caprese(rmh004.data) *** Checking input events. *** Inferring a progression model with the following settings.
Dataset size: n = 7, m = 8. Algorithm: CAPRESE with shrinkage coefficient: 0.5.
The reconstruction has been successfully completed in 00h:00m:00s > rmh004.data = tronco.bootstrap(rmh004.data) Executing now the bootstrap procedure, this may take a long time... Expected completion in approx. 00h:00m:00s
Performed non-parametric bootstrap with 100 resampling and 0.5 as shrinkage parameter.
This model may be compared to the one inferred by processing the regionspecific VAF with a max-mini optimization of most parsimonious evolutionary trees, and performing selection-by-consensus when multiple optimal solutions exist -Supplementary Figure 9 of the reference paper. CAPRESE requires no arbitrarily defined curation criteria to select the optimal tree, as it constructively searches for a solution which, in this case, is analogous in suggesting parallel evolution of subclones via deregulation of the SWI /SNF chromatin-remodeling complex -i.e., as may be noted from multiple clones with distinct PBMR1 mutations.
Moreover, as a further proof of concept, we now consider the somatic mutations made available for two more patients, i.e., EV 002 and EV 007, once again as Bernoulli 0/1 profiles provided in Supplementary Table 3 and Figure 4 of the main study, of which the oncoprints follow in figure 3 .
> oncoprint(example1.ev002, > title="Phylogeny inference -> Multiple biopses of patient EV002 (Gerlinger at al.)") *** Oncoprint for "Phylogeny inferenceMultiple biopses of patient EV002 (Gerlinger at al.)" with attributes: stage=FALSE, hits=TRUE Sorting samples ordering to enhance exclusivity patterns. Setting automatic row font (exponential scaling): 13.6 > oncoprint(example2.ev007, > title="Phylogeny inference -> Multiple biopses of patient EV007 (Gerlinger at al.)") *** Oncoprint for "Phylogeny inferenceMultiple biopses of patient EV007 (Gerlinger at al.)" with attributes: stage=FALSE, hits=TRUE Sorting samples ordering to enhance exclusivity patterns. Setting automatic row font (exponential scaling): 13.8
The inference on such patients is performed again with CAPRESE algorithm with shrinkage coefficient 0.5 (optimal value), and requires less than 1 second in a standard laptop; non-parametric bootstrap confidence is subsequently estimated.
We finally show the reconstructions (figure 4) of the above patients and we observe that once again CAPRESE captures the same clonal evolution depicted Figure 2 : (A) With data provided by Gerlinger et al., we infer a patient-specific clonal evolution from 6 biopsies of a clear cell renal carcinoma (5 primary tumor, 1 from the thrombus in the renal vein, V T ). Validated non-synonymous mutations are selected for VHL, SMARCA4, PTEN, PBMR1, ARID1A, ATM and MSH6 genes. CNAs are detected on 12 chromosomes. For this patient, both region-specific allele frequencies and Bernoulli profiles are provided. Thus, we can extract a clonal tree, signature and diffusion of each clone, by the unsupervised CAPRESE algorithm. (B) The unsupervised model inferred by CAP-RESE predicts an analogous clonal expansion observed in the main paper, and extracted with most parsimonious phylogeny tree reconstruction from allelic frequencies, and hand-curated for selection of the optimal model. For simplicity, we show only expansion of the sub-clones harbouring PTEN 's frame shift mutation. in the reference paper.
Inference by CAPRESE − Multiple biopses of patient EV002

VHL(FS)/PBRM1(FS)
88% (7) SETD2 75% (6) SETD2/TP53 12% (1) PTEN 38% (3) 12% (1) 0 [filter.in] Genes hold: KRAS, NRAS, IDH1, IDH2, TET2 ... [6/7 found] . Selected 10 events, returning. > aCML.alterations = change.color(aCML.alterations, > type="Alteration", new.color="khaki4") > oncoprint(aCML.alterations) *** Oncoprint for "" with attributes: stage=FALSE, hits=TRUE Sorting samples ordering to enhance exclusivity patterns. Setting automatic row font (exponential scaling): 12.3 Moreover, we gave as a further input to CAPRI algorithm patterns of mutual exclusivity among genes: TET2 and IDH2, ASXL1 and SF3B1, NRAS and KRAS.
> aCML.alterations.hypo = hypothesis.add(aCML.alterations, > 'TET2 xor IDH2', XOR('TET2','IDH2')) > aCML.alterations.hypo = hypothesis.add(aCML.alterations.hypo, > 'ASXL1 xor SF3B1', XOR('ASXL1','SF3B1')) > aCML.alterations.hypo = hypothesis.add(aCML.alterations.hypo, > 'NRAS xor KRAS', XOR('NRAS','KRAS')) We conclude by showing the results of the inference from both CAPRESE and CAPRI algorithms in figure 6 .
